TransAct Technologies Secures Major BOHA!® Terminal 2 Upgrade with Leading National Convenience Store Chain
HAMDEN, Conn.–(BUSINESS WIRE)–TransAct® Technologies Incorporated (Nasdaq: TACT), a global leader delivering software-driven technology and printing... Read more.
OneKonnect Appoints Michael Martocci as Chief Executive Officer to Drive Next Phase of Growth
MANASSAS, Va.–(BUSINESS WIRE)–OneKonnect, a leading technology-driven platform specializing in seamless electronic data interchange and connectivity... Read more.
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.11 per Common Limited Partner Unit
BRENTWOOD, Tenn.–(BUSINESS WIRE)–Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today declared its quarterly cash distribution for... Read more.
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the... Read more.
NOV Reports First Quarter 2025 Results
Net Income of $73 million, or $0.19 per share, down $46 million year-over-year Adjusted EBITDA* of $252 million, an increase of $11 million year-over-year Cash flow... Read more.
ISS Joins Glass Lewis in Urging Parkland Shareholders to Vote For Meaningful Change
Highlights Troubling Pattern of Mismanagement, Volatile and Deteriorating Financial Performance, Failure to Execute, and Repeated Efforts to Disenfranchise Shareholders... Read more.
Sangoma Announces Date of Third Quarter Fiscal 2025 Financial Results and Conference Call
MARKHAM, Ontario–(BUSINESS WIRE)–Sangoma Technologies Corporation (TSX: STC; Nasdaq: SANG) (“Sangoma” or the “Company”), a trusted industry leader... Read more.
Affinia Therapeutics to Present New Data on its AFTX-201 Program in BAG3 Dilated Cardiomyopathy, BBB-Penetrant AAV Capsids, and Proprietary Manufacturing Technology at the 28th Annual American Society of Gene & Cell Therapy 2025 Annual Meeting
Company’s lead program, AFTX-201 in BAG3 dilated cardiomyopathy, on track for IND submission fourth quarter of 2025 with potential initial readouts of clinical... Read more.
Teradyne Reports First Quarter 2025 Results
Revenue towards the high end and earnings above Q1 guidance ranges Revenue of $686 million in Q1’25, up 14% from Q1’24 Strong year-over-year growth driven by... Read more.
WM Announces First Quarter 2025 Earnings
Strong Operational Performance Combined with WM Healthcare Solutions Results Deliver Outsized Growth WM Adds Two Recycling Automation Projects in Key Markets During... Read more.